Ruinuo Jia
机构：First Affiliated Hospital of Henan University of Science and Technology · ORCID：0000-0003-2634-0807
发表论文 7 篇 · 总被引 17 次 · h-index 1
代表论文
- Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial (2024 · Journal of Clinical Oncology · 被引 17)
- A multicenter, randomized phase 2 study evaluating the efficacy and safety of HLX43 (an anti-PD-L1 ADC) in recurrent/metastatic esophageal squamous cell carcinoma. (2026 · Journal of Clinical Oncology)
- Camrelizumab combined with concurrent chemoradiotherapy for locally recurrent esophageal cancer: A single-arm, open-label study. (2025 · Journal of Clinical Oncology)
- Additional file 1: Figure S1. of Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer (2016 · Figshare)
- Additional file 2: Table S1. of Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer (2016 · Figshare)
- Additional file 2: Table S1. of Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer (2016 · Figshare)